SCHEMBL30748950

SCHEMBL30748950

O=C1CCc2cncnc2N1c1ccc(N2CCOCC2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.46
HPGD P15428 3/20 0.46
HSD17B10 Q99714 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
MAPT P10636 3/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 2/20 0.46
HTT P42858 2/20 0.46
MEN1 O00255 1/20 0.46
GAA P10253 1/20 0.46
RECQL P46063 1/20 0.46
KMT2A Q03164 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 1/20 0.41
POLB P06746 1/20 0.40
ALOX15 P16050 1/20 0.40
CYP11B2 P19099 2/20 0.38
OPRM1 P35372 1/20 0.37
OPRL1 P41146 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30748753 0.82 ALDH1A1 (0.44) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL30748776 0.80 ALDH1A1 (0.45) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL31691214 0.74 ALDH1A1 (0.41) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL1269304 0.67 ALDH1A1 (0.65) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL30031226 0.65 MTOR (0.36) CYP11B2OPRM1OPRL1CYP11B1
SCHEMBL28301513 0.65 ALDH1A1 (0.64) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL23981694 0.64 ALDH1A1 (0.59) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL30146714 0.64 ALDH1A1 (0.60) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL13518832 0.64 ALDH1A1 (0.59) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT
SCHEMBL31104721 0.64 ALDH1A1 (0.58) ALDH1A1HPGDHSD17B10SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4565588-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF Suzhou Keen Therapeutics Co., Ltd. (CN) 2025-06-11 EP disclosed
WO-2023241620-A1 BIOLOGICALLY ACTIVE COMPOUNDS AND METHODS THEREOF SUZHOU KEEN THERAPEUTICS CO., LTD. (CN) 2023-12-21 WO disclosed